Delivra Health Brands Inc. (TSX-V:DHB, OTCQB:DHBUF, FRA:3F0) CEO Gord Davey talked with Proactive about the company's launch of LivRelief Itch Cream, a new product designed to provide relief for people suffering from itching associated with psoriasis, eczema, bug bites and skin rashes.
During the interview, Davey explained that LivRelief Itch Cream is based on a patented process and combines itch relief with moisturizing properties to help soothe irritated skin. The product is designed for individuals dealing with persistent itching and skin discomfort, offering support during what Davey described as the "irritable stage" of these common conditions.
Davey highlighted that the cream incorporates Delivra Health Brands' patented delivery system, which is intended to penetrate the skin and help alleviate itching and discomfort caused by constant scratching. He noted that the addition of moisturizing agents is an important feature, helping to support skin health while providing relief.
The discussion also covered the market opportunity for the product. Referencing data from the Canadian Dermatology Association, the interview noted that approximately 17% of Canadians experience some form of itching during their lives. Davey said the company conducts extensive market research before launching new products and develops solutions that respond to consumer demand.
Proactive: Welcome back inside our Proactive newsroom. Joining me now is Gord Davey, CEO of Delivra Health Brands. Gord, it's great to see you again. How are you?
Gord Davey: Hey, as always it's great to see you and excited to speak with you today.
Especially because you're launching a brand new product. Congratulations. This is an itch relief cream, and there are so many people looking for solutions to persistent itching. Tell us about it.
This is really exciting. This is a patented process that we have, and it's called LivRelief Itch Cream. Anyone with psoriasis, eczema, bug bites or rashes can benefit from this product. It helps people get through that irritable stage and also contains a moisturizing agent to help soothe the skin while alleviating itching. It's a wonderful product and we're happy to be launching it very shortly.
I understand the product was developed with people who have sensitive skin in mind. Features like hypoallergenic formulations are important to consumers.
They really are. When people are suffering from these ailments, it's important to find the right product. It needs to help with the itch while also moisturizing the affected area to help prevent the issue from returning. One of the great things about this product is that it uses Delivra's patented delivery system, which gets into the skin and helps alleviate itching and discomfort associated with constant scratching. Again, it's a wonderful product that we're just bringing to market.
The Canadian Dermatology Association says about 17% of Canadians will experience some type of itching during their lives. That sounds like a significant market opportunity.
That's one of the reasons we're making this product. Whenever we develop new items, we conduct market research behind these types of products. This is another patented process from Dr. Joe Gabriel, whose company we acquired. The products we're launching now are ones the marketplace has been asking for. Again, whether it's psoriasis, eczema or bug bites, this is a product designed to help people through those issues.
Talk about the innovation side of the business and your commitment to developing products consumers need.
That's exactly what we do. We are a health and wellness company dedicated to innovation. We focus heavily on market data and market research when developing products, and we will continue to launch new products going forward. This is one we've been working on for quite some time, and we're very pleased that it's finally ready to reach the market.
It's the LivRelief Itch Cream. Gord, thanks for the update.
Thank you very much. As always, it's a pleasure talking to you.
Gord Davey, CEO of Delivra Health Brands.
Quotes have been lightly edited for clarity and style